Geode Capital Management’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-136,955
| Closed | -$113K | – | 4767 |
|
|
2023
Q3 | $113K | Buy |
136,955
+40,625
| +42% | +$33.4K | ﹤0.01% | 4205 |
|
|
2023
Q2 | $89K | Hold |
96,330
| – | – | ﹤0.01% | 4372 |
|
|
2023
Q1 | $73.1K | Hold |
96,330
| – | – | ﹤0.01% | 4434 |
|
|
2022
Q4 | $241K | Buy |
96,330
+5,515
| +6% | +$9.47K | ﹤0.01% | 3998 |
|
|
2022
Q3 | $126K | Hold |
90,815
| – | – | ﹤0.01% | 4454 |
|
|
2022
Q2 | $114K | Buy |
90,815
+6,644
| +8% | +$13.9K | ﹤0.01% | 4541 |
|
|
2022
Q1 | $244K | Sell |
84,171
-590
| -0.7% | -$1.42K | ﹤0.01% | 4283 |
|
|
2021
Q4 | $194K | Buy |
84,761
+20,737
| +32% | +$48.1K | ﹤0.01% | 4489 |
|
|
2021
Q3 | $163K | Buy |
64,024
+6,415
| +11% | +$16.3K | ﹤0.01% | 4520 |
|
|
2021
Q2 | $164K | Buy |
57,609
+16,111
| +39% | +$46.4K | ﹤0.01% | 4412 |
|
|
2021
Q1 | $129K | Sell |
41,498
-231
| -0.6% | -$785 | ﹤0.01% | 4243 |
|
|
2020
Q4 | $109K | Hold |
41,729
| – | – | ﹤0.01% | 4045 |
|
|
2020
Q3 | $120K | Hold |
41,729
| – | – | ﹤0.01% | 3859 |
|
|
2020
Q2 | $143K | Sell |
41,729
-20,035
| -32% | -$56.5K | ﹤0.01% | 3763 |
|
|
2020
Q1 | $122K | Sell |
61,764
-13,989
| -18% | -$51.3K | ﹤0.01% | 3701 |
|
|
2019
Q4 | $303K | Buy |
75,753
+1,268
| +2% | +$4.31K | ﹤0.01% | 3674 |
|
|
2019
Q3 | $237K | Buy |
74,485
+9,239
| +14% | +$27.1K | ﹤0.01% | 3710 |
|
|
2019
Q2 | $254K | Buy |
65,246
+29,510
| +83% | +$562K | ﹤0.01% | 3721 |
|
|
2019
Q1 | $868K | Hold |
35,736
| – | – | ﹤0.01% | 3219 |
|
|
2018
Q4 | $719K | Buy |
35,736
+4,297
| +14% | +$98.9K | ﹤0.01% | 3239 |
|
|
2018
Q3 | $969K | Buy |
+31,439
| New | +$842K | ﹤0.01% | 3234 |
|
|
2017
Q3 | – | Sell |
-3,448
| Closed | -$23K | – | 4076 |
|
|
2017
Q2 | $23K | Hold |
3,448
| – | – | ﹤0.01% | 4035 |
|
|
2017
Q1 | $27K | Hold |
3,448
| – | – | ﹤0.01% | 4022 |
|
|
2016
Q4 | $33K | Hold |
3,448
| – | – | ﹤0.01% | 3963 |
|
|
2016
Q3 | $115K | Hold |
3,448
| – | – | ﹤0.01% | 3775 |
|
|
2016
Q2 | $148K | Hold |
3,448
| – | – | ﹤0.01% | 3685 |
|
|
2016
Q1 | $83 | Hold |
3,448
| – | – | ﹤0.01% | 3879 |
|
|
2015
Q4 | $99K | Hold |
3,448
| – | – | ﹤0.01% | 3886 |
|
|
2015
Q3 | $112K | Hold |
3,448
| – | – | ﹤0.01% | 3870 |
|
|
2015
Q2 | $127K | Buy |
3,448
+2,560
| +288% | +$98.4K | ﹤0.01% | 3722 |
|
|
2015
Q1 | $40K | Hold |
888
| – | – | ﹤0.01% | 3874 |
|
|
2014
Q4 | $53K | Hold |
888
| – | – | ﹤0.01% | 3868 |
|
|
2014
Q3 | $73K | Hold |
888
| – | – | ﹤0.01% | 3800 |
|
|
2014
Q2 | $122K | Hold |
888
| – | – | ﹤0.01% | 3654 |
|
|
2014
Q1 | $136K | Hold |
888
| – | – | ﹤0.01% | 3599 |
|
|
2013
Q4 | $134K | Buy |
888
+719
| +425% | +$117K | ﹤0.01% | 3535 |
|
|
2013
Q3 | $31K | Hold |
169
| – | – | ﹤0.01% | 3620 |
|
|
2013
Q2 | $21K | Buy |
+169
| New | +$24.7K | ﹤0.01% | 3589 |
|
Other funds holding ACER
Geode Capital Management's ACER Position: Q4 2023 in Review
Geode Capital Management sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 136,955 shares — an estimated $113K sold.
Geode Capital Management first reported a position in ACER in Q2 2013 and held it in 38 quarters. The position peaked at $969K in Q3 2018. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.
- Geode Capital Management reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
- Geode Capital Management sold 136,955 Acer Therapeutics Inc shares in Q4 2023, an estimated $113K.
- Geode Capital Management first reported a position in Acer Therapeutics Inc in Q2 2013 and held it in 38 quarters.
- Geode Capital Management's Acer Therapeutics Inc position peaked at $969K in Q3 2018.
- 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.
Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.